Articles
COVID-19 Impact on Pharmaceutical Industry Comment
Reflecting on the beginning of the COVID-19 outbreak 12 months ago, it is clear that those pharma companies who responded early to the warning...
Press Releases
FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ” orally active” therapeutic alternative for COVID 19
“With the more we understand of COVID 19 the less we fear it and it is through this understanding that we can potentially create...
News
Dachser Shanghai is recognized as CEIV Pharma Certified by IATA
International Logistics service provider Dachser received the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification from IATA for its Shanghai...
Articles
Time for a Truly Agile, Global Pharmaceutical Supply chain
Agile supply chains have distinct attributes that help manage vulnerability, disruptions and risk. Recent events demonstrate how valuable an agile process team approach can...
Articles
Fill and Finish in Clinical Development: Getting it Right from the Start
Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including...
Articles
The impact of the COVID 19 Pandemic on Global Pharmaceutical Growth
Vaccine production is very complex making specialist expertise vital to ensuring both the safety and efficacy of the final product. Depending on the type...
Drug Research
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read